Blaine Labs Inc Tripenicol S Antifungal Solution , 1.25 FL OZ bottle recall: CGMP Deviations; the firm discontinued required stability testing
CGMP Deviations; the firm discontinued required stability testing for products on the market still within expiry
The hazard: Labelling or manufacturing-practice failure
The defect here is documentary: wrong strength on the label, a mismatched barcode, or records that do not demonstrate the product was made correctly.
What the notice says: CGMP Deviations; the firm discontinued required stability testing for products on the market still within expiry
Why it matters: The label, the strength printed on it, the barcode or the manufacturing records do not meet federal requirements. The practical danger is someone taking the wrong drug or the wrong dose while believing they have the right one.
Symptoms and when to call a doctor
If you may have taken a product that turned out to be a different drug or strength from the one on the label, call your prescriber, and call Poison Control on 1-800-222-1222 if you feel unwell. Describe what the pack said and what you actually took.
This page is general information, not medical advice. If you feel unwell, a clinician who can see you is the only person able to judge your case.
Recall details
- Recall number
- D-0694-2026
- Published
- July 8, 2026
- Risk level
- Class II
- Status
- Ongoing
- Issued by
- U.S. Food and Drug Administration
- Brand
- Blaine Labs Inc
- Product type
- Prescription & OTC drugs
- Units affected
- 144 bottles
- Distribution
- Nationwide
- Made in
- United States
- Lot / code info
- Lot #BL3411R, Exp 6/8/2027
Products covered by this recall
TRIPENICOL S Antifungal Solution (Undecylenic Acid 25%), 1.25 FL OZ (37.5 mL) bottle, Manufactured For: Trifluent Pharma, LLC, San Antonio, TX 78213, NDC 73352-550-01.
Check your product
The notice names 7 codes you can read straight off the package. Type the one printed on yours and the list below narrows to it.
Lot or batch code
Usually ink-stamped near the seam, the cap or the bottom of the pack.
- BL3411R
- Exp 6
- 2027 — 144 bottles
Best-by / use-by date
Printed beside the lot code, not on the price sticker.
- 2027 — 144 bottles
NDC number
On the carton and again on the bottle or blister label.
- 73352-550-01
Package size
Match the net weight or the piece count on the front of the pack.
- 1.25 FL OZ
- 37.5 mL
Codes are lifted verbatim from the FDA — Drug enforcement notice. A code that is missing here may still be covered — the official notice is the complete list.
What to do about Labelling
Blaine Labs Inc — The defect here is documentary: wrong strength on the label, a mismatched barcode, or records that do not demonstrate the product was made correctly.
- Compare the lot number and strength on your pack with the codes above and with what your prescription actually says.
- If what you were dispensed does not match your prescription, call the pharmacy before taking another dose.
- Keep taking the medicine as prescribed unless the notice or your prescriber says otherwise.
- Return the affected pack to the pharmacy for a replacement from a good lot.
What the company owes you
A recalled medicine is the manufacturer’s cost to carry, not yours or your pharmacist’s.
- The purchase price or co-pay is refundable, and so is the cost of returning the product if they ask you to ship it.
- Ask the pharmacy to handle the claim where they can — they process recall returns in bulk and it saves you the correspondence.
- Keep the carton, the leaflet and the pharmacy label together until the claim is closed.
- Costs beyond the price of the medicine need to go to the company directly, in writing, with the recall number quoted.
Company contact: Blaine Labs Inc — 11037 Lockport Pl, Santa Fe Springs, CA, 90670-4634
The official notice
This page summarises a notice published by U.S. Food and Drug Administration. The agency notice is the authoritative version — read it before you act, and treat it as the final word if anything here looks different.
Open the FDA — Drug enforcement record U.S. Food and Drug Administration recalls
Questions people ask about this recall
Why was Blaine Labs Inc prescription & otc drugs recalled?
CGMP Deviations; the firm discontinued required stability testing for products on the market still within expiry CGMP Deviations; the firm discontinued required stability testing for products on the market still within expiry
How do I know if I have the recalled product?
Match the codes printed on your package against the notice: lot code BL3411R, Exp 6, 2027 — 144 bottles; best-by date 2027 — 144 bottles. If the code on your package is not on that list, your unit is outside the recall.
What should I do with it right now?
Compare the lot number and strength on your pack with the codes above and with what your prescription actually says.
Can I get my money back?
The purchase price or co-pay is refundable, and so is the cost of returning the product if they ask you to ship it.
Where was the recalled product sold?
It was distributed nationwide.
Related recalls
-
Class II · 4 months ago
Blaine Labs Inc Terpenicol Antifungal Solution, acid 25%), 1.0 Fl Oz recall: CGMP Deviations; the firm discontinued required stability testing
CGMP Deviations; the firm discontinued required stability testing for products on the market still within expiry
-
Class II · 4 months ago
Blaine Labs Inc Fungal Fusion Eradication Solution, Antifungal & Antimicrobial Kit recall: CGMP Deviations; the firm discontinued required stability testing
CGMP Deviations; the firm discontinued required stability testing for products on the market still within expiry
-
Class I · 4 months ago
Blaine Labs Inc Revitaderm Wound Care Gel, Benzalkonium Chloride 0.1% recall: Microbial contamination of Non-Sterile Product: samples identified
Microbial contamination of Non-Sterile Product: samples identified the presence of Lysinibacillus fusiformis and other Bacillus spp
-
Class II · 4 months ago
Blaine Labs Inc Revitaderm Wound Care, First Aid Antiseptic Gel recall: CGMP Deviations; product manufactured in the same facility under the same
CGMP Deviations; product manufactured in the same facility under the same conditions as the product found to be contaminated
-
Class II · 4 months ago
Blaine Labs Inc vite20 Antifungal Cream, , 0.54 OZ bottle recall: CGMP Deviations; the firm discontinued required stability testing
CGMP Deviations; the firm discontinued required stability testing for products on the market still within expiry
-
Class II · 4 months ago
Blaine Labs Inc Trifluent Pharma Tridergel Wound Care Gel, , 1.0 fl oz recall: CGMP Deviations: product manufactured in the same facility under the same
CGMP Deviations: product manufactured in the same facility under the same conditions as the product found to be contaminated